Tonix Pharmaceuticals Holding Corp at ThinkEquity Conference Transcript
It's great to be here today presenting at the ThinkEquity Conference on behalf of Tonix Pharmaceutics. I am Jessica Morris, Chief Operating Officer. We are a publicly traded company on Nasdaq, so this is our standard safe harbor statement. I will be making forward-looking statements, so I refer you to our SEC filings for complete information.
So who is Tonix Pharmaceuticals? We are a biopharmaceutical company committed to developing as well as marketing therapeutics to treat pain, neurologic, psychiatric, addiction conditions, which all fall under our CNS or Central Nervous System portfolio. But we also focus on other areas of high unmet need, we believe these areas are within immunology, infectious disease, and rare disease. But today, I'm going to mostly focus on our CNS portfolio, this has our latest-stage asset, as well as the assets with the nearest term milestones.
So again, we are a biopharmaceutical company, but we have evolved a lot over the last decade since we've been publicly traded, from a company with just a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
